FDA Approves New Breast Cancer Drug: The Food and Drug Administration approved a new late-stage breast cancer drug developed by Genentech in South San Francisco. It combines the widely used breast cancer medicine Herceptin with a powerful toxin to more effectively kill cancer cells while potentially reducing side effects. Marianne Favro-reports
NBC Bay Area-
View more videos at: http://nbcbayarea.com.
